APA (7th ed.) Citation

Catellani, S., Pierri, I., Gobbi, M., Poggi, A., & Zocchi, M. R. (2011). Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Catellani, Silvia, Ivana Pierri, Marco Gobbi, Alessandro Poggi, and Maria Raffaella Zocchi. Imatinib Treatment Induces CD5+ B Lymphocytes and IgM Natural Antibodies with Anti-leukemic Reactivity in Patients with Chronic Myelogenous Leukemia. Public Library of Science (PLoS), 2011.

MLA (8th ed.) Citation

Catellani, Silvia, et al. Imatinib Treatment Induces CD5+ B Lymphocytes and IgM Natural Antibodies with Anti-leukemic Reactivity in Patients with Chronic Myelogenous Leukemia. Public Library of Science (PLoS), 2011.